Trial · NCT01414608
Results by group100
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 100
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival Rate at 5 Years | Standard Chemoradiation | 71 | 95% Confidence Interval 66 to 75 | Percentage of participants | |
| Overall Survival Rate at 5 Years | Standard Chemoradiation With Adjuvant Chemotherapy | 72 | 95% Confidence Interval 67 to 76 | Percentage of participants | |
| Progression-free Survival Rate at 5 Years | Standard Chemoradiation | 62 | 95% Confidence Interval 57 to 66 | Percentage of participants | |
| Progression-free Survival Rate at 5 Years | Standard Chemoradiation With Adjuvant Chemotherapy | 63 | 95% Confidence Interval 58 to 68 | Percentage of participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation | Abdominal pain | 13 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation With Adjuvant Chemotherapy | Abdominal pain | 14 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation | Alanine aminotransferase increased | 4 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation With Adjuvant Chemotherapy | Alanine aminotransferase increased | 2 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation | Allergic reaction/hypersensitivity | 1 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation With Adjuvant Chemotherapy | Allergic reaction/hypersensitivity | 2 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation | Alopecia | 0 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation With Adjuvant Chemotherapy | Alopecia | 1 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation | Anemia | 32 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation With Adjuvant Chemotherapy | Anemia | 64 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation | Aspartate aminotransferase increased | 3 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation With Adjuvant Chemotherapy | Aspartate aminotransferase increased | 2 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation | Colitis | 2 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation With Adjuvant Chemotherapy | Colitis | 2 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation | Colonic obstruction | 1 | Participants | |
| Number of Participants With Adverse Events (Grade 3 or Higher) in First Year | Standard Chemoradiation With Adjuvant Chemotherapy | Colonic obstruction | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01414608/results